About Novalis Biotech
Novalis Biotech is a Financial Services company based in Ghent (Belgium). Early-stage venture capital investment is provided in life sciences. It operates on a Professional Services model. Novalis Biotech offers products and services including Biotech Incubation. Its focus areas include Finance, Venture Capital and Life Sciences Investment.
Company details
Funding and strategic support are offered by Novalis Biotech Incubation to early-stage startups in the life sciences sector. Focus is placed on enabling technologies including research tools, bioinformatics, genomics, diagnostics, and digital health. Investments range from pre-seed to Series A stages, with an emphasis on capital-light platform technologies. Connections within professional and academic networks are shared to shape business strategies and create value for stakeholders. The portfolio includes innovative companies in MedTech, AI imaging, and biomanufacturing across various global locations.
Products & Services of Novalis Biotech
Novalis Biotech offers a comprehensive portfolio of products and services, including Biotech Incubation.
Early-stage funding is provided for life sciences startups.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Novalis Biotech
Novalis Biotech is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.
Funding and strategic support are offered by Novalis Biotech Incubation to early-stage startups in the life sciences sector. Focus is placed on enabling technologies including research tools, bioinformatics, genomics, diagnostics, and digital health. Investments range from pre-seed to Series A stages, with an emphasis on capital-light platform technologies. Connections within professional and academic networks are shared to shape business strategies and create value for stakeholders. The portfolio includes innovative companies in MedTech, AI imaging, and biomanufacturing across various global locations.
Novalis Biotech offers Biotech Incubation.